Akero Therapeutics Inc (AKRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 192,679 | 63,247 | 47,245 | 64,788 | 147,835 |
| Marketable Securities | 99,191 | 39,586 | 78,040 | 71,612 | N/A |
| TOTAL | $298,033 | $113,193 | $126,218 | $138,049 | $150,073 |
| Non-Current Assets | |||||
| PPE Net | 137 | N/A | N/A | N/A | N/A |
| Other Non-Current Assets | 1,866 | 865 | 403 | 69 | 70 |
| TOTAL | $2,003 | $865 | $403 | $69 | $70 |
| Total Assets | $300,036 | $114,058 | $126,621 | $138,118 | $150,143 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,636 | 2,536 | 1,535 | 947 | 93 |
| Accrued Expenses | 7,378 | 7,857 | 6,751 | 8,422 | 6,632 |
| TOTAL | $12,014 | $10,393 | $8,286 | $9,369 | $6,725 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,564 | 2 | 12 | 23 | 34 |
| TOTAL | $1,564 | $2 | $12 | $23 | $34 |
| Total Liabilities | $13,578 | $10,395 | $8,298 | $9,392 | $6,759 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 34,722 | 34,701 | 28,674 | 28,608 | 28,559 |
| Common Shares | 4 | 3 | 3 | 3 | 3 |
| Retained earnings | -179,816 | -158,413 | -142,206 | -130,320 | -114,709 |
| Other shareholders' equity | 16 | 90 | 45 | -6 | 0 |
| TOTAL | $286,458 | $103,663 | $118,323 | $128,726 | $143,384 |
| Total Liabilities And Equity | $300,036 | $114,058 | $126,621 | $138,118 | $150,143 |